Adicet Bio, Inc. — Director's Dealing 2020

Dec 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2020-12-01

Reporting Person: Sanna Bastiano (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-01	Stock Option (Right to Buy)	$12.00	A	28828	Acquired	2030-11-30	Common Stock (28828)	Direct

Footnotes

F1: 33% of the shares shall become exercisable on December 1, 2021, and the remaining 67% of the shares shall vest in 24 equal monthly installments thereafter.